Dynavax Technologies
DVAX
#5017
Rank
C$2.60 B
Marketcap
C$22.20
Share price
0.00%
Change (1 day)
12.80%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Last known market cap: C$2.60 Billion

As of November 2026 Dynavax Technologies has a market cap of C$2.60 Billion. This makes Dynavax Technologies the world's 5017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026C$2.60 B5.42%
2025C$2.47 B0.86%
2024C$2.45 B2.31%
2023C$2.39 B30.12%
2022C$1.84 B-14.36%
2021C$2.15 B244.02%
2020C$0.62 B-0.22%
2019C$0.62 B-20.03%
2018C$0.78 B-45%
2017C$1.42 B596.61%
2016C$0.20 B-84.13%
2015C$1.28 B150.33%
2014C$0.51 B-6.13%
2013C$0.54 B5.84%
2012C$0.51 B20.97%
2011C$0.42 B15.8%
2010C$0.36 B355.99%
2009C$81.09 M99.24%
2008C$40.7 M-79.92%
2007C$0.20 B-52.25%
2006C$0.42 B265.82%
2005C$0.11 B-48.99%
2004C$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$229.12 B 8,687.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$343.96 B 13,091.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$53.23 B 1,941.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$300.25 B 11,415.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$486.59 B 18,561.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$397.17 B 15,132.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$139.50 B 5,250.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
C$0.41 B-84.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$70.59 B 2,607.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel